Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept
2016 · BMC Musculoskeletal Disorders · 72 citations
https://doi.org/10.1186/s12891-016-1082-z
S
Sheila Kelly
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
40
Papers
903
Citations
14
h-index
17
i10-index
Sheila Kelly is an academic researcher from Bristol-Myers Squibb (United States). The author has contributed to research in topics: Rheumatoid Arthritis Research and Therapies & Pneumonia and Respiratory Infections & Advanced Biosensing Techniques and Applications. The author has an h-index of 14, co-authored 34 publications.
Papers by this author
worksA window of opportunity for abatacept in RA: is disease duration an independent predictor of low disease activity/remission in clinical practice?
2017 · Clinical Rheumatology · 22 citations
https://doi.org/10.1007/s10067-017-3588-7
Current Practice Patterns and Educational Needs of Rheumatologists Who Manage Patients with Rheumatoid Arthritis
2014 · Rheumatology and Therapy · 10 citations
https://doi.org/10.1007/s40744-014-0004-5
Comparative Effectiveness of Abatacept vs. Tofacitinib in Rheumatoid Arthritis Patients who are CCP+
2023 · Rheumatology and Therapy · 1 citations
https://doi.org/10.1007/s40744-022-00523-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat